KKR is quietly building a medtech manufacturing powerhouse around Precipart
KKR is building Allyntra around Precipart to expand precision engineering and medical device manufacturing. See what the strategy means.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Why Novanta’s June healthcare conference appearance matters after its Q1 revenue rebound
Medtech suppliers are under pressure to prove growth quality. Novanta’s Jefferies appearance may sharpen the investor debate.
Medical Devices & Diagnostics
Can Covalon Technologies convert IV contamination education into adoption of VALGuard and CovaClear?
Covalon Technologies is gaining momentum in vascular access and wound care. Read why its latest milestones could shape medtech growth next.